All news

Baird upgrades Humana to strong-buy on star ratings

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Robert W. Baird upgraded Humana (NYSE:HUM) to strong-buy, joining Morgan Stanley and Leerink Partners in raising ratings. The consensus is now Moderate Buy with an average price target of $445.74, against a recent price of $431.87. Humana beat revenue and EPS expectations and said 95% of Medicare Advantage members are in 4-star or higher plans for 2027.

Read original source

HUM company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.